Industry

About

Poultry Diagnostics Market

Poultry Diagnostics Market Study by ELISA and PCR Tests for Avian Salmonellosis, Avian Influenza, Newcastle Disease, Avian Mycoplasmosis, Avian Pasteurellosis, and Others from 2024 to 2034

Analysis of Poultry Diagnostics Market covering 30+ countries including analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more

FACT6747MR
21 May 2024
Healthcare
170 Pages
96 Tables
129 Figures

Poultry Diagnostics Market Outlook (2024 to 2034)

The global poultry diagnostics market is calculated to reach US$ 374.9 million in 2024. Fact.MR’s recently updated industry report reveals that the worldwide revenue from the sales of poultry diagnostic services is forecasted to rise at a CAGR of 8.5% and end up at US$ 847.6 million by 2034.

Increasing demand for poultry food products on a global scale is a key driver for global poultry diagnostics market growth. In addition to the huge meat industry, widespread demand and use of eggs in multiple sectors, including food and personal care, is contributing to the sales growth of poultry diagnostic test kits. For healthy livestock production, regular monitoring of animal health is extremely necessary.

Rising incidence of zoonotic ailments coupled with strict food safety regulations and government initiatives toward food security are set to offer lucrative opportunities for key players in the poultry diagnostics market. The poultry industry comprises chickens, ducks, turkeys, waterfowl, and other birds, creating unique veterinary needs.

With a wide range of diseases potentially affecting poultry animals, innovations in terms of toxicology, serology, pathology, and microbiology are set to influence long-term demand growth for poultry diagnostic technologies.

North America is set to hold 23.9% of the global poultry diagnostics market share in 2024.

This high market share is attributed to its advanced healthcare infrastructure for animal care, presence of multinational players, and increasing awareness among farmers regarding poultry diseases.

The East Asia poultry diagnostics market size is forecasted to reach US$ 195.8 million by 2034.

Recent bird flu outbreaks in Asian countries, high demand for meat and poultry food, and ongoing advancements in the field of veterinary diagnostics, including veterinary hematology analyzers and veterinary imaging systems, are supporting overall market growth.

Europe is one of the world’s key producers and exporters of poultry products. In Europe, the United Kingdom is expected to hold a substantial market share throughout the study period (2024 to 2034). Rising prevalence of zoonotic diseases in Europe is majorly contributing to pouty diagnostics demand growth.

Report Attribute	Detail
Poultry Diagnostics Market Size (2024E)	US$ 374.9 Million
Forecasted Market Value (2034F)	US$ 847.6 Million
Global Market Growth Rate (2024 to 2034)	8.5% CAGR
South Korea Market Value (2034F)	US$ 45.2 Million
ELISA (Enzyme-linked Immunoassays) Test Demand Growth Rate (2024 to 2034)	8.6% CAGR
Key Companies Profiled	IDEXX Laboratories; GD Animal Health; IDvet; AffiniTech LTD; Qiagen N.V.; Thermo Fisher Scientific; Zoetis; AgroBioTek Internacional; Boehringer Ingelheim; MEGACOR Diagnostik GmbH; BioNote; BioChek; BioInGenTech; Bioneer Corporation.

What is Augmenting Demand for Poultry Diagnostic Technologies?

“Rising Prevalence of Infectious Diseases Pushing Demand for Advanced Poultry Diagnostic Technologies”

Poultry disease outbreaks are the prime factor responsible for the high demand for poultry diagnostic kits. These infections related to flocks are negatively affecting the global poultry industry. As a result, there have been continuous efforts to increase awareness about these diseases among farmers, which are caused by various bacteria, fungi, viruses, protozoon pathogens, environmental stress, and lack of nutritional poultry feed.

Foodborne and zoonotic diseases are directly linked with poultry. Eradication and control of foodborne and zoonotic pathogens present a major challenge to the poultry industry. Zoonotic means that the disease can be passed from one species to another.

Poultry-infected disease affects the consumers of its products. One of the most common diseases is salmonella infection in chickens. Also, Marek’s disease and avian reticuloendotheliosis are the most common infections occurring in birds, and these infections cause cancer-like diseases. The rising prevalence of such diseases is posing a major threat to the poultry food product industry, and, in turn, boosting the demand for poultry diagnostics.

“High Convenience and Effective Results Increasing Adoption of Rapid Detection Kits”

In rural areas, farmers and people are more close to farm animals, which increases disease transmission risk from animal to person. Rising use of point-of-care and molecular diagnostic solutions for veterinary purposes is emerging as a notable poultry diagnostics market trend.

Point-of-care diagnostic tests are a cost-effective and efficient way to detect diseases among livestock. The rising popularity of rapid testing is further increasing the demand for RT-PCR (real-time polymerase chain reaction) test kits.

Poultry diagnostics helps farmers in producing healthy livestock and mitigating the risk of infectious disease transmission. Use of molecular and point-of-care diagnostics aids in potentially saving future medical costs associated with disease growth by providing quick results at affordable rates.

Which Factors are Impacting Sales Growth of Poultry Diagnostic Kits?

“Lack of Awareness Regarding Livestock Diseases and High Cost of Poultry Diagnostics”

Improper poultry management knowledge and lack of awareness of infectious poultry diseases are primarily lowering the adoption of poultry diagnostic solutions. In poor regions, inadequate presence of veterinary healthcare facilities further raises the risk of disease progression. Small-scale farmers are also deterred from carrying out livestock health tests due to the high costs associated with diagnostics.

Start-up Ecosystem

Based in Canada, Alpha Phenomics is a start-up that offers thermal imaging technology for poultry animals. The company’s innovation is aiding veterinarians in getting information on poultry animal health quickly and efficiently.
Brainwired is an Indian start-up that develops livestock health monitoring and tracking systems. The system offered by Brainwired is helping livestock farmers keep track of the health of their farm animals.

Country-wise Analysis

How are Government Initiatives Driving Use of Poultry Diagnostic Technologies in the United States?

“Regular Updates and Awareness of Animal Health and Diseases Boosting Adoption of Precise Poultry Testing Solutions”

Attribute	United States
Market Value (2024E)	US$ 39.9 Million
Growth Rate (2024 to 2034)	8.9% CAGR
Projected Value (2034F)	US$ 93.9 Million

Livestock farmers in the United States prefer precision farming practices. They are forefront of the adoption of advanced technologies and equipment, which is contributing to effective poultry management. Government authorities related to livestock farming in the United States provide various portals that can deliver animal healthcare information to the farmers.

These portals allow farmers to remember preventive diagnostics, dietary information, required diagnostic tests, and missing vaccines. Moreover, programs by the government to promote animal healthcare are expected to further boost market growth over the coming years in the United States.

What is the Demand Outlook for Poultry Diagnostics in South Korea?

“High Consumption of Meat Products Increasing Use of Reliable Diagnostic Solutions for Healthy Livestock Production”

Attribute	South Korea
Market Value (2024E)	US$ 18.6 Million
Growth Rate (2024 to 2034)	9.3% CAGR
Projected Value (2034F)	US$ 45.2 Million

South Koreans are major consumers of chicken meat and eggs. High intake of non-vegetarian food is boosting the demand for poultry products. This is driving the attention of South Korean farmers on effective poultry management, which is further increasing the sales of diagnostic technologies. The rising government initiatives to create awareness of poultry diseases are also supporting the market growth in South Korea.

Category-wise Analysis

Which Poultry Diagnostic Tests are Gaining Popularity?

“Polymerase Chain Reaction (PCR) Tests Quick and Reliable Diagnostic Solutions”

Attribute	Polymerase Chain Reaction (PCR) Tests
Segment Value (2024E)	US$ 202.1 Million
Growth Rate (2024 to 2034)	8.4% CAGR
Projected Value (2034F)	US$ 451.8 Million

Polymerase chain reaction (PCR) test types are gaining traction in poultry diagnostics and care. These PCR technologies are highly advanced, specific, and rapid compared to its counterpart such as enzyme-linked adsorption assay tests. The latest RT-PCR tests allow for quick detection of pathogens making it a precise diagnostic mode. Thus, PCR tests contribute to effective poultry disease management.

Furthermore, for the identification of antibodies in the blood, ELISA tests are widely used. ELISA provides efficiency in checking for infectious diseases such as avian influenza, which is a major concern in developed countries. ELISA has proven to be exceptionally reliable as well as cost-effective. These factors are expected to increase the acceptance of ELISA across the globe.

Which Disease Accounts for High Share of Poultry Diagnostics?

“Avian Influenza Most Prevalent Pathogenic Infection among Birds”

Avian influenza is known to cause respiratory diseases, decreased egg production, and subclinical infections. In some cases, the high pathogenic (HPAI) variant of the virus is more harmful to domestic flocks. Elevated pathogenic kind causes systemic diseases and mortality.

On the other hand, avian salmonellosis is the most common bacteria causing poultry disease. Salmonella causes infections such as pullorum fever, paratyphoid, and fowl typhoid. Chickens and turkeys are most frequently infected due to salmonella.

Why are Virology Testing Services in Such High Demand?

“High Prevalence of Viral Diseases Such as Avian Encephalomyelitis and Infectious Bronchitis”

Attribute	Virology
Segment Value (2024E)	US$ 140.2 Million
Growth Rate (2024 to 2034)	8% CAGR
Projected Value (2034F)	US$ 301.7 Million

Increasing prevalence of viral diseases among poultry animals such as avian encephalomyelitis, infectious bronchitis, Fowlpox, and Newcastle disease are driving the demand for virology diagnostic tests. Such viral infections can cause serious outbreaks, leading to high mortality rates and loss to the farmers. Thus, this is raising the demand for virology services for timely detection, identification, and treatment of infectious diseases.

Competitive Landscape

The global poultry diagnostics market is characterized by the presence of established companies. New companies are adopting research and development tactics to increase their presence in the market. Leading producers are relying on strategies such as mergers and acquisitions, global expansions, and collaborations with research institutes to develop advanced products and boost market reach.

In January 2024, Alveo Technologies announced a partnership with x-OvO, Royal GD, and Pharmsure for the development of avian influenza molecular testing solutions.
In 2020, BioChek announced the acquisition of BIOTECON, a producer of PCR-based solutions for food safety diagnostics.
In July 2018, Zoetis completed the acquisition of Abaxis, a global manufacturer of on-site veterinary testing equipment such as POC diagnostic solutions, to strengthen its position in the field of veterinary diagnostics.
In February 2018, Biochek announced the launch of avian influenza H5-H7-H9 multiplex, a PCR test kit to diagnose avian influenza.

Fact.MR provides detailed information about the price points of key providers of poultry diagnostic solutions positioned across the world, sales growth, production capacity, and speculative technological expansion, in the recently updated market report.

Key Segments of Poultry Diagnostics Market Research

By Test :
- ELISA (Enzyme-linked Immunoassays) Tests
- PCR (Polymerase Chain Reaction) Tests
By Disease :
- Avian Salmonellosis
- Avian Influenza
- Newcastle Disease
- Avian Mycoplasmosis
- Avian Pasteurellosis
- Infectious Bronchitis
- Infectious Bursal Disease
- Avian Encephalomyelitis
- Avian Reovirus
- Chicken Anaemia
By Service :
- Bacteriology
- Virology
- Parasitology
By Region :
- North America
- Latin America
- Western Europe
- Eastern Europe
- East Asia
- South Asia & Pacific
- Middle East & Africa

- Frequently Asked Questions -

How big is the poultry diagnostics market in 2024?

The global poultry diagnostics market is anticipated to reach US$ 374.9 million in 2024.

What is the forecasted CAGR for the poultry diagnostics market?

Demand for poultry diagnostic solutions is foreseen to rise at a CAGR of 8.5% from 2024 to 2034.

What is the projected global market value for 2034?

The market for poultry diagnostics is projected to reach US$ 847.6 million by 2034.

At what rate are the sales of poultry diagnostic technologies expected to increase in North America?

The North American market is calculated to rise at a CAGR of 8.7% through 2034.

How fast is demand for poultry diagnostic solutions expanding in South Korea?

Sales of poultry diagnostic solutions in South Korea are forecasted to reach US$ 45.2 million by 2034.

Which testing service is widely demanded across the world?

Virology testing services are estimated to hold 37.4% of the global market share in 2024.

Who are the leading providers of poultry diagnostic technologies?

Top poultry diagnostic companies are IDEXX Laboratories, GD Animal Health, IDvet, AffiniTech LTD, Qiagen N.V., Thermo Fisher Scientific, and Zoetis.

Table of Content

1. Executive Summary
2. Industry Introduction, including Taxonomy and Market Definition
3. Market Trends and Success Factors, including Macro-economic Factors, Market Dynamics, and Recent Industry Developments
4. Global Market Demand Analysis 2019 to 2023 and Forecast 2024 to 2034, including Historical Analysis and Future Projections
5. Pricing Analysis
6. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034
- 6.1. Test
- 6.2. Disease
- 6.3. Service
7. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, by Test
- 7.1. ELISA (Enzyme-linked Immunoassays) Tests
- 7.2. PCR (Polymerase Chain Reaction) Tests
8. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, by Disease
- 8.1. Avian Salmonellosis
- 8.2. Avian Influenza
- 8.3. Newcastle Disease
- 8.4. Avian Mycoplasmosis
- 8.5. Avian Pasteurellosis
- 8.6. Infectious Bronchitis
- 8.7. Infectious Bursal Disease
- 8.8. Avian Encephalomyelitis
- 8.9. Avian Reovirus
- 8.10. Chicken Anaemia
9. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, by Service
- 9.1. Bacteriology
- 9.2. Virology
- 9.3. Parasitology
10. Global Market Analysis 2019 to 2023 and Forecast 2024 to 2034, by Region
- 10.1. North America
- 10.2. Latin America
- 10.3. Western Europe
- 10.4. Eastern Europe
- 10.5. East Asia
- 10.6. South Asia & Pacific
- 10.7. Middle East & Africa
11. North America Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries
12. Latin America Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries
13. Western Europe Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries
14. Eastern Europe Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries
15. East Asia Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries
16. South Asia & Pacific Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries
17. Middle East & Africa Sales Analysis 2019 to 2023 and Forecast 2024 to 2034, by Key Segments and Countries
18. Sales Forecast 2024 to 2034 by Test, Disease, Service, and Region for 30 Countries
19. Competition Outlook, including Market Structure Analysis, Company Share Analysis by Key Players, and Competition Dashboard
20. Company Profile
- 20.1. IDEXX Laboratories
- 20.2. GD Animal Health
- 20.3. IDvet
- 20.4. AffiniTech LTD
- 20.5. Qiagen N.V.
- 20.6. Thermo Fisher Scientific
- 20.7. Zoetis
- 20.8. AgroBioTek Internacional
- 20.9. Boehringer Ingelheim
- 20.10. MEGACOR Diagnostik GmbH
- 20.11. BioNote
- 20.12. BioChek
- 20.13. BioInGenTech
- 20.14. Bioneer Corporation
21. Assumptions and Acronyms Used
22. Research Methodology

List Of Table

Table 01: Global Market Value (US$ Mn) Analysis, by Test, 2019 to 2023

Table 02: Global Market Value (US$ Mn) Analysis, by Test, 2024 to 2034

Table 03: Global Market Value (US$ Mn) Opportunity Analysis, by Test, 2024 to 2034

Table 04: Global Market Value (US$ Mn) Analysis, by Disease, 2019 to 2023

Table 05: Global Market Value (US$ Mn) Analysis, by Disease, 2024 to 2034

Table 06: Global Market Value (US$ Mn) Opportunity Analysis, by Disease, 2024 to 2034

Table 07: Global Market Value (US$ Mn) Analysis, by Service, 2019 to 2023

Table 08: Global Market Value (US$ Mn) Analysis, by Service, 2024 to 2034

Table 09: Global Market Value (US$ Mn) Opportunity Analysis, by Service, 2024 to 2034

Table 10: Global Market Value (US$ Mn) Analysis, by Region, 2019 to 2023

Table 11: Global Market Value (US$ Mn) Analysis, by Region, 2024 to 2034

Table 12: Global Market Value (US$ Mn) Opportunity Analysis, by Region, 2024 to 2034

Table 13: North America Market Value (US$ Mn) Analysis, by Country, 2019 to 2023

Table 14: North America Market Value (US$ Mn) Analysis, by Country, 2024 to 2034

Table 15: North America Market Value (US$ Mn) Opportunity Analysis, by Country, 2024 to 2034

Table 16: North America Market Value (US$ Mn) Analysis, by Test, 2019 to 2023

Table 17: North America Market Value (US$ Mn) Analysis, by Test, 2024 to 2034

Table 18: North America Market Value (US$ Mn) Opportunity Analysis, by Test, 2024 to 2034

Table 19: North America Market Value (US$ Mn) Analysis, by Disease, 2019 to 2023

Table 20: North America Market Value (US$ Mn) Analysis, by Disease, 2024 to 2034

Table 21: North America Market Value (US$ Mn) Opportunity Analysis, by Disease, 2024 to 2034

Table 22: North America Market Value (US$ Mn) Analysis, by Service, 2019 to 2023

Table 23: North America Market Value (US$ Mn) Analysis, by Service, 2024 to 2034

Table 24: North America Market Value (US$ Mn) Opportunity Analysis, by Service, 2024 to 2034

Table 25: Latin America Market Value (US$ Mn) Analysis, by Country, 2019 to 2023

Table 26: Latin America Market Value (US$ Mn) Analysis, by Country, 2024 to 2034

Table 27: Latin America Market Value (US$ Mn) Opportunity Analysis, by Country, 2024 to 2034

Table 28: Latin America Market Value (US$ Mn) Analysis, by Test, 2019 to 2023

Table 29: Latin America Market Value (US$ Mn) Analysis, by Test, 2024 to 2034

Table 30: Latin America Market Value (US$ Mn) Opportunity Analysis, by Test, 2024 to 2034

Table 31: Latin America Market Value (US$ Mn) Analysis, by Disease, 2019 to 2023

Table 32: Latin America Market Value (US$ Mn) Analysis, by Disease, 2024 to 2034

Table 33: Latin America Market Value (US$ Mn) Opportunity Analysis, by Disease, 2024 to 2034

Table 34: Latin America Market Value (US$ Mn) Analysis, by Service, 2019 to 2023

Table 35: Latin America Market Value (US$ Mn) Analysis, by Service, 2024 to 2034

Table 36: Latin America Market Value (US$ Mn) Opportunity Analysis, by Service, 2024 to 2034

Table 37: Western Europe Market Value (US$ Mn) Analysis, by Country, 2019 to 2023

Table 38: Western Europe Market Value (US$ Mn) Analysis, by Country, 2024 to 2034

Table 39: Western Europe Market Value (US$ Mn) Opportunity Analysis, by Country, 2024 to 2034

Table 40: Western Europe Market Value (US$ Mn) Analysis, by Test, 2019 to 2023

Table 41: Western Europe Market Value (US$ Mn) Analysis, by Test, 2024 to 2034

Table 42: Western Europe Market Value (US$ Mn) Opportunity Analysis, by Test, 2024 to 2034

Table 43: Western Europe Market Value (US$ Mn) Analysis, by Disease, 2019 to 2023

Table 44: Western Europe Market Value (US$ Mn) Analysis, by Disease, 2024 to 2034

Table 45: Western Europe Market Value (US$ Mn) Opportunity Analysis, by Disease, 2024 to 2034

Table 46: Western Europe Market Value (US$ Mn) Analysis, by Service, 2019 to 2023

Table 47: Western Europe Market Value (US$ Mn) Analysis, by Service, 2024 to 2034

Table 48: Western Europe Market Value (US$ Mn) Opportunity Analysis, by Service, 2024 to 2034

Table 49: Eastern Europe Market Value (US$ Mn) Analysis, by Country, 2019 to 2023

Table 50: Eastern Europe Market Value (US$ Mn) Analysis, by Country, 2024 to 2034

Table 51: Eastern Europe Market Value (US$ Mn) Opportunity Analysis, by Country, 2024 to 2034

Table 52: Eastern Europe Market Value (US$ Mn) Analysis, by Test, 2019 to 2023

Table 53: Eastern Europe Market Value (US$ Mn) Analysis, by Test, 2024 to 2034

Table 54: Eastern Europe Market Value (US$ Mn) Opportunity Analysis, by Test, 2024 to 2034

Table 55: Eastern Europe Market Value (US$ Mn) Analysis, by Disease, 2019 to 2023

Table 56: Eastern Europe Market Value (US$ Mn) Analysis, by Disease, 2024 to 2034

Table 57: Eastern Europe Market Value (US$ Mn) Opportunity Analysis, by Disease, 2024 to 2034

Table 58: Eastern Europe Market Value (US$ Mn) Analysis, by Service, 2019 to 2023

Table 59: Eastern Europe Market Value (US$ Mn) Analysis, by Service, 2024 to 2034

Table 60: Eastern Europe Market Value (US$ Mn) Opportunity Analysis, by Service, 2024 to 2034

Table 61: East Asia Market Value (US$ Mn) Analysis, by Country, 2019 to 2023

Table 62: East Asia Market Value (US$ Mn) Analysis, by Country, 2024 to 2034

Table 63: East Asia Market Value (US$ Mn) Opportunity Analysis, by Country, 2024 to 2034

Table 64: East Asia Market Value (US$ Mn) Analysis, by Test, 2019 to 2023

Table 65: East Asia Market Value (US$ Mn) Analysis, by Test, 2024 to 2034

Table 66: East Asia Market Value (US$ Mn) Opportunity Analysis, by Test, 2024 to 2034

Table 67: East Asia Market Value (US$ Mn) Analysis, by Disease, 2019 to 2023

Table 68: East Asia Market Value (US$ Mn) Analysis, by Disease, 2024 to 2034

Table 69: East Asia Market Value (US$ Mn) Opportunity Analysis, by Disease, 2024 to 2034

Table 70: East Asia Market Value (US$ Mn) Analysis, by Service, 2019 to 2023

Table 71: East Asia Market Value (US$ Mn) Analysis, by Service, 2024 to 2034

Table 72: East Asia Market Value (US$ Mn) Opportunity Analysis, by Service, 2024 to 2034

Table 73: South Asia & Pacific Market Value (US$ Mn) Analysis, by Country, 2019 to 2023

Table 74: South Asia & Pacific Market Value (US$ Mn) Analysis, by Country, 2024 to 2034

Table 75: South Asia & Pacific Market Value (US$ Mn) Opportunity Analysis, by Country, 2024 to 2034

Table 76: South Asia & Pacific Market Value (US$ Mn) Analysis, by Test, 2019 to 2023

Table 77: South Asia & Pacific Market Value (US$ Mn) Analysis, by Test, 2024 to 2034

Table 78: South Asia & Pacific Market Value (US$ Mn) Opportunity Analysis, by Test, 2024 to 2034

Table 79: South Asia & Pacific Market Value (US$ Mn) Analysis, by Disease, 2019 to 2023

Table 80: South Asia & Pacific Market Value (US$ Mn) Analysis, by Disease, 2024 to 2034

Table 81: South Asia & Pacific Market Value (US$ Mn) Opportunity Analysis, by Disease, 2024 to 2034

Table 82: South Asia & Pacific Market Value (US$ Mn) Analysis, by Service, 2019 to 2023

Table 83: South Asia & Pacific Market Value (US$ Mn) Analysis, by Service, 2024 to 2034

Table 84: South Asia & Pacific Market Value (US$ Mn) Opportunity Analysis, by Service, 2024 to 2034

Table 85: MEA Market Value (US$ Mn) Analysis, by Country, 2019 to 2023

Table 86: MEA Market Value (US$ Mn) Analysis, by Country, 2024 to 2034

Table 87: MEA Market Value (US$ Mn) Opportunity Analysis, by Country, 2024 to 2034

Table 88: MEA Market Value (US$ Mn) Analysis, by Test, 2019 to 2023

Table 89: MEA Market Value (US$ Mn) Analysis, by Test, 2024 to 2034

Table 90: MEA Market Value (US$ Mn) Opportunity Analysis, by Test, 2024 to 2034

Table 91: MEA Market Value (US$ Mn) Analysis, by Disease, 2019 to 2023

Table 92: MEA Market Value (US$ Mn) Analysis, by Disease, 2024 to 2034

Table 93: MEA Market Value (US$ Mn) Opportunity Analysis, by Disease, 2024 to 2034

Table 94: MEA Market Value (US$ Mn) Analysis, by Service, 2019 to 2023

Table 95: MEA Market Value (US$ Mn) Analysis, by Service, 2024 to 2034

Table 96: MEA Market Value (US$ Mn) Opportunity Analysis, by Service, 2024 to 2034

List Of Figures

Figure 01: Global Market Value (US$ Mn) Historical Analysis, 2019 to 2023

Figure 02: Global Market Value (US$ Mn) Forecast and Analysis, 2024 to 2034

Figure 03: Global Market Value Y-o-Y Growth and Forecast, 2019 to 2034

Figure 04: Global Market Incremental $ Opportunity, 2024 to 2034

Figure 05: Global Market Share and BPS Analysis by Test, 2024 & 2034

Figure 06: Global Market Y-o-Y Growth Projections by Test, 2024 to 2034

Figure 07: Global Market Attractiveness Analysis by Test, 2024 to 2034

Figure 08: Global Market Share and BPS Analysis by Disease, 2024 & 2034

Figure 09: Global Market Y-o-Y Growth Projections by Disease, 2024 to 2034

Figure 10: Global Market Attractiveness Analysis by Disease, 2024 to 2034

Figure 11: Global Market Share and BPS Analysis by Service, 2024 & 2034

Figure 12: Global Market Y-o-Y Growth Projections by Service, 2024 to 2034

Figure 13: Global Market Attractiveness Analysis by Service, 2024 to 2034

Figure 14: Global Market Share and BPS Analysis by Region, 2024 & 2034

Figure 15: Global Market Y-o-Y Growth Projections by Region, 2024 to 2034

Figure 16: Global Market Attractiveness Analysis by Region, 2024 to 2034

Figure 17: North America Market Value (US$ Mn) Historical Analysis, 2019 to 2023

Figure 18: North America Market Value (US$ Mn) Forecast and Analysis, 2024 to 2034

Figure 19: North America Market Value Y-o-Y Growth and Forecast, 2034

Figure 20: North America Market Incremental $ Opportunity, 2024 to 2034

Figure 21: North America Market Share Analysis by Country, 2024 & 2034

Figure 22: North America Market Y-o-Y Growth Projection by Country, 2024 to 2034

Figure 23: North America Market Attractiveness Analysis by Country, 2024 to 2034

Figure 24: North America Market Share and BPS Analysis by Test, 2024 & 2034

Figure 25: North America Market Y-o-Y Growth Projections by Test, 2024 to 2034

Figure 26: North America Market Attractiveness Analysis by Test, 2024 to 2034

Figure 27: North America Market Share and BPS Analysis by Disease, 2024 & 2034

Figure 28: North America Market Y-o-Y Growth Projections by Disease, 2024 to 2034

Figure 29: North America Market Attractiveness Analysis by Disease, 2024 to 2034

Figure 30: North America Market Share and BPS Analysis by Service, 2024 & 2034

Figure 31: North America Market Y-o-Y Growth Projections by Service, 2024 to 2034

Figure 32: North America Market Attractiveness Analysis by Service, 2024 to 2034

Figure 33: Latin America Market Value (US$ Mn) Historical Analysis, 2019 to 2023

Figure 34: Latin America Market Value (US$ Mn) Forecast and Analysis, 2024 to 2034

Figure 35: Latin America Market Value Y-o-Y Growth and Forecast, 2019 to 2034

Figure 36: Latin America Market Incremental $ Opportunity, 2024 to 2034

Figure 37: Latin America Market Share Analysis by Country, 2024 & 2034

Figure 38: Latin America Market Y-o-Y Growth Projection by Country, 2024 to 2034

Figure 39: Latin America Market Attractiveness Analysis by Country, 2024 to 2034

Figure 40: Latin America Market Share and BPS Analysis by Test, 2024 & 2034

Figure 41: Latin America Market Y-o-Y Growth Projections by Test, 2024 to 2034

Figure 42: Latin America Market Attractiveness Analysis by Test, 2024 to 2034

Figure 43: Latin America Market Share and BPS Analysis by Disease, 2024 & 2034

Figure 44: Latin America Market Y-o-Y Growth Projections by Disease, 2024 to 2034

Figure 45: Latin America Market Attractiveness Analysis by Disease, 2024 to 2034

Figure 46: Latin America Market Share and BPS Analysis by Service, 2024 & 2034

Figure 47: Latin America Market Y-o-Y Growth Projections by Service, 2024 to 2034

Figure 48: Latin America Market Attractiveness Analysis by Service, 2024 to 2034

Figure 49: Western Europe Market Value (US$ Mn) Historical Analysis, 2019 to 2023

Figure 50: Western Europe Market Value (US$ Mn) Forecast and Analysis, 2024 to 2034

Figure 51: Western Europe Market Value Y-o-Y Growth and Forecast, 2019 to 2034

Figure 52: Western Europe Market Incremental $ Opportunity, 2024 to 2034

Figure 53: Western Europe Market Share Analysis by Country, 2024 & 2034

Figure 54: Western Europe Market Y-o-Y Growth Projection by Country, 2024 to 2034

Figure 55: Western Europe Market Attractiveness Analysis by Country, 2024 to 2034

Figure 56: Western Europe Market Share and BPS Analysis by Test, 2024 & 2034

Figure 57: Western Europe Market Y-o-Y Growth Projections by Test, 2024 to 2034

Figure 58: Western Europe Market Attractiveness Analysis by Test, 2024 to 2034

Figure 59: Western Europe Market Share and BPS Analysis by Disease, 2024 & 2034

Figure 60: Western Europe Market Y-o-Y Growth Projections by Disease, 2024 to 2034

Figure 61: Western Europe Market Attractiveness Analysis by Disease, 2024 to 2034

Figure 62: Western Europe Market Share and BPS Analysis by Service, 2024 & 2034

Figure 63: Western Europe Market Y-o-Y Growth Projections by Service, 2024 to 2034

Figure 64: Western Europe Market Attractiveness Analysis by Service, 2024 to 2034

Figure 66: Eastern Europe Market Value (US$ Mn) Historical Analysis, 2019 to 2023

Figure 67: Eastern Europe Market Value (US$ Mn) Forecast and Analysis, 2024 to 2034

Figure 68: Eastern Europe Market Value Y-o-Y Growth and Forecast, 2019 to 2034

Figure 69: Eastern Europe Market Incremental $ Opportunity, 2024 to 2034

Figure 70: Eastern Europe Market Share Analysis by Country, 2024 & 2034

Figure 71: Eastern Europe Market Y-o-Y Growth Projection by Country, 2024 to 2034

Figure 72: Eastern Europe Market Attractiveness Analysis by Country, 2024 to 2034

Figure 73: Eastern Europe Market Share and BPS Analysis by Test, 2024 & 2034

Figure 74: Eastern Europe Market Y-o-Y Growth Projections by Test, 2024 to 2034

Figure 75: Eastern Europe Market Attractiveness Analysis by Test, 2024 to 2034

Figure 76: Eastern Europe Market Share and BPS Analysis by Disease, 2024 & 2034

Figure 77: Eastern Europe Market Y-o-Y Growth Projections by Disease, 2024 to 2034

Figure 78: Eastern Europe Market Attractiveness Analysis by Disease, 2024 to 2034

Figure 79: Eastern Europe Market Share and BPS Analysis by Service, 2024 & 2034

Figure 80: Eastern Europe Market Y-o-Y Growth Projections by Service, 2024 to 2034

Figure 81: Eastern Europe Market Attractiveness Analysis by Service, 2024 to 2034

Figure 82: East Asia Market Value (US$ Mn) Historical Analysis, 2019 to 2023

Figure 83: East Asia Market Value (US$ Mn) Forecast and Analysis, 2024 to 2034

Figure 84: East Asia Market Value Y-o-Y Growth and Forecast, 2019 to 2034

Figure 85: East Asia Market Incremental $ Opportunity, 2024 to 2034

Figure 86: East Asia Market Share Analysis by Country, 2024 & 2034

Figure 87: East Asia Market Y-o-Y Growth Projection by Country, 2024 to 2034

Figure 88: East Asia Market Attractiveness Analysis by Country, 2024 to 2034

Figure 89: East Asia Market Share and BPS Analysis by Test, 2024 & 2034

Figure 90: East Asia Market Y-o-Y Growth Projections by Test, 2024 to 2034

Figure 91: East Asia Market Attractiveness Analysis by Test, 2024 to 2034

Figure 92: East Asia Market Share and BPS Analysis by Disease, 2024 & 2034

Figure 93: East Asia Market Y-o-Y Growth Projections by Disease, 2024 to 2034

Figure 94: East Asia Market Attractiveness Analysis by Disease, 2024 to 2034

Figure 95: East Asia Market Share and BPS Analysis by Service, 2024 & 2034

Figure 96: East Asia Market Y-o-Y Growth Projections by Service, 2024 to 2034

Figure 97: East Asia Market Attractiveness Analysis by Service, 2024 to 2034

Figure 98: South Asia & Pacific Market Value (US$ Mn) Historical Analysis, 2019 to 2023

Figure 99: South Asia & Pacific Market Value (US$ Mn) Forecast and Analysis, 2024 to 2034

Figure 100: South Asia & Pacific Market Value Y-o-Y Growth and Forecast, 2019 to 2034

Figure 101: South Asia & Pacific Market Incremental $ Opportunity, 2024 to 2034

Figure 102: South Asia & Pacific Market Share Analysis by Country, 2024 & 2034

Figure 103: South Asia & Pacific Market Y-o-Y Growth Projection by Country, 2024 to 2034

Figure 104: South Asia & Pacific Market Attractiveness Analysis by Country, 2024 to 2034

Figure 105: South Asia & Pacific Market Share and BPS Analysis by Test, 2024 & 2034

Figure 106: South Asia & Pacific Market Y-o-Y Growth Projections by Test, 2024 to 2034

Figure 107: South Asia & Pacific Market Attractiveness Analysis by Test, 2024 to 2034

Figure 108: South Asia & Pacific Market Share and BPS Analysis by Disease, 2024 & 2034

Figure 109: South Asia & Pacific Market Y-o-Y Growth Projections by Disease, 2024 to 2034

Figure 110: South Asia & Pacific Market Attractiveness Analysis by Disease, 2024 to 2034

Figure 111: South Asia & Pacific Market Share and BPS Analysis by Service, 2024 & 2034

Figure 112: South Asia & Pacific Market Y-o-Y Growth Projections by Service, 2024 to 2034

Figure 113: South Asia & Pacific Market Attractiveness Analysis by Service, 2024 to 2034

Figure 114: MEA Market Value (US$ Mn) Historical Analysis, 2019 to 2023

Figure 115: MEA Market Value (US$ Mn) Forecast and Analysis, 2024 to 2034

Figure 116: MEA Market Value Y-o-Y Growth and Forecast, 2019 to 2034

Figure 117: MEA Market Incremental $ Opportunity, 2024 to 2034

Figure 118: MEA Market Share Analysis by Country, 2024 & 2034

Figure 119: MEA Market Y-o-Y Growth Projection by Country, 2024 to 2034

Figure 120: MEA Market Attractiveness Analysis by Country, 2024 to 2034

Figure 121: MEA Market Share and BPS Analysis by Test, 2024 & 2034

Figure 122: MEA Market Y-o-Y Growth Projections by Test, 2024 to 2034

Figure 123: MEA Market Attractiveness Analysis by Test, 2024 to 2034

Figure 124: MEA Market Share and BPS Analysis by Disease, 2024 & 2034

Figure 125: MEA Market Y-o-Y Growth Projections by Disease, 2024 to 2034

Figure 126: MEA Market Attractiveness Analysis by Disease, 2024 to 2034

Figure 127: MEA Market Share and BPS Analysis by Service, 2024 & 2034

Figure 128: MEA Market Y-o-Y Growth Projections by Service, 2024 to 2034

Figure 129: MEA Market Attractiveness Analysis by Service, 2024 to 2034

Poultry Diagnostics Market

Free Sample Buy Report Now

Poultry Diagnostics Market

Poultry Diagnostics Market Study by ELISA and PCR Tests for Avian Salmonellosis, Avian Influenza, Newcastle Disease, Avian Mycoplasmosis, Avian Pasteurellosis, and Others from 2024 to 2034

Poultry Diagnostics Market Outlook (2024 to 2034)

What is Augmenting Demand for Poultry Diagnostic Technologies?

Which Factors are Impacting Sales Growth of Poultry Diagnostic Kits?

Start-up Ecosystem

Country-wise Analysis

How are Government Initiatives Driving Use of Poultry Diagnostic Technologies in the United States?

What is the Demand Outlook for Poultry Diagnostics in South Korea?

Category-wise Analysis

Which Poultry Diagnostic Tests are Gaining Popularity?

Which Disease Accounts for High Share of Poultry Diagnostics?

Why are Virology Testing Services in Such High Demand?

Competitive Landscape

Key Segments of Poultry Diagnostics Market Research

By Test :

By Disease :

By Service :

By Region :

- Frequently Asked Questions -

Table of Content

List Of Table

List Of Figures